Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life.

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  Oct. 19, 2016 | FORBES: Is It A Buyer's Market For Private Biotech Deals?

  Oct. 17, 2016 | CLOSE CONCERNS: Renova Therapeutics to begin in-human trials of RT-200 gene transfer therapy for type 2 diabetes

View All News
Subscribe to receive company press releases and announcements